Assessing the Role of 3D Contrast-Enhanced CT Radiomics in Anticipating Neoadjuvant Chemotherapy Outcomes for Esophagogastric Junction Adenocarcinoma: Findings from a Dual-Center Investigation - Quiz - MDSpire

Assessing the Role of 3D Contrast-Enhanced CT Radiomics in Anticipating Neoadjuvant Chemotherapy Outcomes for Esophagogastric Junction Adenocarcinoma: Findings from a Dual-Center Investigation

  • By

  • Chenglong Luo

  • Jing Li

  • Wanling Mu

  • Mengchen Yuan

  • Pengchao Zhan

  • Yiyang Liu

  • Yue Zhou

  • Liming Li

  • Changmao Ding

  • Xuejun Chen

  • Jianbo Gao

  • January 23, 2026

  • 0 min

Share

Original Source(s)

Assessing the Role of 3D Contrast-Enhanced CT Radiomics in Anticipating Neoadjuvant Chemotherapy Outcomes for Esophagogastric Junction Adenocarcinoma: Findings from a Dual-Center Investigation

  • by Chenglong Luo, Jing Li, Wanling Mu, Mengchen Yuan, Pengchao Zhan, Yiyang Liu, Yue Zhou, Liming Li, Changmao Ding, Xuejun Chen, Jianbo Gao

  • January 23, 2026

Related Content

Text-image alignment for ILD imaging: linking CXR evidence to CT quantification

Experiences in Clinical Implementation of Online Adaptive Radiotherapy for Prostate Cancer: Enhancing Treatment Efficiency

Evaluating the Diagnostic Utility of Advanced CT Radiomics and Deep Learning for Distinguishing Pediatric Peripheral Neuroblastoma from Ganglioneuroblastoma